AAAAAA

   
Results: 1-20 |
Results: 20
Ab initio relativistic spin-polarized theory of angle-resolved photoemission
Authors: Woods, M Ernst, A Strange, P Temmerman, WM
Citation: M. Woods et al., Ab initio relativistic spin-polarized theory of angle-resolved photoemission, J PHYS-COND, 13(38), 2001, pp. 8607-8624
Simple rules for determining valencies of f-electron systems
Authors: Petit, L Svane, A Szotek, Z Strange, P Winter, H Temmerman, WM
Citation: L. Petit et al., Simple rules for determining valencies of f-electron systems, J PHYS-COND, 13(38), 2001, pp. 8697-8706
Relativistic theory of magnetic X-ray scattering
Authors: Arola, E Strange, P
Citation: E. Arola et P. Strange, Relativistic theory of magnetic X-ray scattering, APPL PHYS A, 73(6), 2001, pp. 667-671
Pressure-induced valence transitions in rare earth chalcogenides and pnictides
Authors: Svane, A Strange, P Temmerman, WM Szotek, Z Winter, H Petit, L
Citation: A. Svane et al., Pressure-induced valence transitions in rare earth chalcogenides and pnictides, PHYS ST S-B, 223(1), 2001, pp. 105-116
First principles relativistic theory of photoemission from magnetic surfaces
Authors: Woods, M Strange, P Ernst, A Temmerman, WM
Citation: M. Woods et al., First principles relativistic theory of photoemission from magnetic surfaces, J MAGN MAGN, 226, 2001, pp. 1032-1034
Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes
Authors: Bode, BW Strange, P
Citation: Bw. Bode et P. Strange, Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes, DIABET CARE, 24(1), 2001, pp. 69-72
Pharmacodynamic and pharmacokinetic properties of a premixed 85/15 human insulin preparation
Authors: Mudaliar, SRD Mohideen, P Baxi, SC Joyce, M Armstrong, DA Strange, P Henry, RR
Citation: Srd. Mudaliar et al., Pharmacodynamic and pharmacokinetic properties of a premixed 85/15 human insulin preparation, CLIN THER, 23(3), 2001, pp. 404-412
Intracellular cytokine production by fetal and adult monocytes
Authors: Hebra, A Strange, P Egbert, JM Ali, M Mullinax, A Buchanan, E
Citation: A. Hebra et al., Intracellular cytokine production by fetal and adult monocytes, J PED SURG, 36(9), 2001, pp. 1321-1326
Systematics for trivalent and divalent rare-earth sulphides
Authors: Temmerman, WM Svane, A Strange, P Szotek, Z Winter, H
Citation: Wm. Temmerman et al., Systematics for trivalent and divalent rare-earth sulphides, PHIL MAG B, 80(6), 2000, pp. 1179-1191
How to investigate and analyse clinical incidents: Clinical risk unit and association of litigation and risk management protocol
Authors: Vincent, C Taylor-Adams, S Chapman, EJ Hewett, D Prior, S Strange, P Tizzard, A
Citation: C. Vincent et al., How to investigate and analyse clinical incidents: Clinical risk unit and association of litigation and risk management protocol, BR MED J, 320(7237), 2000, pp. 777-781
Ab initio theory of valency in ytterbium compounds
Authors: Svane, A Temmerman, WM Szotek, Z Petit, L Strange, P Winter, H
Citation: A. Svane et al., Ab initio theory of valency in ytterbium compounds, PHYS REV B, 62(20), 2000, pp. 13394-13399
Repaglinide in type 2 diabetes: A 24-week, fixed-dose efficacy and safety study
Authors: Jovanovic, L Dailey, G Huang, WC Strange, P Goldstein, BJ
Citation: L. Jovanovic et al., Repaglinide in type 2 diabetes: A 24-week, fixed-dose efficacy and safety study, J CLIN PHAR, 40(1), 2000, pp. 49-57
Pharmacokinetics of repaglinide in subjects with renal impairment
Authors: Marbury, TC Ruckle, JL Hatorp, V Andersen, MP Nielsen, KK Huang, WC Strange, P
Citation: Tc. Marbury et al., Pharmacokinetics of repaglinide in subjects with renal impairment, CLIN PHARM, 67(1), 2000, pp. 7-15
Viewpoint
Authors: Strange, P
Citation: P. Strange, Viewpoint, POWER ENG J, 13(6), 1999, pp. 286-286
Repaglinide versus glyburide: a one-year comparison trial
Authors: Marbury, T Huang, WC Strange, P Lebovitz, H
Citation: T. Marbury et al., Repaglinide versus glyburide: a one-year comparison trial, DIABET RE C, 43(3), 1999, pp. 155-166
Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin - absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects
Authors: Mudaliar, SR Lindberg, FA Joyce, M Beerdsen, P Strange, P Lin, A Henry, RR
Citation: Sr. Mudaliar et al., Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin - absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects, DIABET CARE, 22(9), 1999, pp. 1501-1506
Repaglinide pharmacokinetics in healthy young adult and elderly subjects
Authors: Hatorp, V Huang, WC Strange, P
Citation: V. Hatorp et al., Repaglinide pharmacokinetics in healthy young adult and elderly subjects, CLIN THER, 21(4), 1999, pp. 702-710
Electronic configuration of Yb compounds
Authors: Temmerman, WM Szotek, Z Svane, A Strange, P Winter, H Delin, A Johansson, B Eriksson, O Fast, L Wills, JM
Citation: Wm. Temmerman et al., Electronic configuration of Yb compounds, PHYS REV L, 83(19), 1999, pp. 3900-3903
Understanding the valency of rare earths from first-principles theory
Authors: Strange, P Svane, A Temmerman, WM Szotek, Z Winter, H
Citation: P. Strange et al., Understanding the valency of rare earths from first-principles theory, NATURE, 399(6738), 1999, pp. 756-758
Pharmacokinetic profiles of repaglinide in elderly subjects with type 2 diabetes
Authors: Hatorp, V Huang, WC Strange, P
Citation: V. Hatorp et al., Pharmacokinetic profiles of repaglinide in elderly subjects with type 2 diabetes, J CLIN END, 84(4), 1999, pp. 1475-1478
Risultati: 1-20 |